Internal Medicine, Endocrinology, Diabetes, & Metabolism · Caguas, PR
NPI
1922091784
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
C/Y #26 Urb. Mariolga, Ave. Luis Munoz Marin
Caguas, PR, 00725
Phone (787) 286-9055
Medicare paid, 2024
$15K
182 services
Medicare patients, 2024
115
Average age 77
Drug cost, 2024
$5.7M
36,525 prescriptions
Company payments, 2025
$187
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edna G Melendez Reyes was code 99214 (office e&m - established), 115 times for 85 patients. In total Edna G Melendez Reyes billed 182 services in 5 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 115 | 85 | $91.97 | $11K |
| 99213 Office E&M - Established | Office | 60 | 48 | $61.93 | $3,716 |
By year: 2022 $20K for 264 services; 2023 $20K for 262 services; 2024 $15K for 182 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edna G Melendez Reyes prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 6,223 prescriptions and refills. In total Edna G Melendez Reyes wrote 36,525 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 6,223 | 9,235 | 1,034 | $421K |
| Atorvastatin Calcium Generic | 1,651 | 2,708 | 364 | $14K |
| Levothyroxine Sodium Generic | 1,650 | 2,644 | 318 | $18K |
| Rosuvastatin Calcium Generic | 1,548 | 2,476 | 342 | $18K |
| Metformin Hcl Generic | 1,527 | 2,551 | 344 | $8,937 |
| Jardiance Empagliflozin | 1,114 | 1,493 | 208 | $907K |
| Farxiga Dapagliflozin Propanediol | 1,109 | 1,426 | 221 | $829K |
| Losartan Potassium Generic | 917 | 1,605 | 208 | $8,764 |
| Gabapentin Generic | 856 | 1,220 | 150 | $8,488 |
| Simvastatin Generic | 805 | 1,238 | 171 | $4,988 |
| Glipizide Er Glipizide | 747 | 1,213 | 142 | $17K |
| Amlodipine Besylate Generic | 712 | 1,082 | 147 | $3,694 |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 644 | 803 | 124 | $479K |
| Humalog Insulin Lispro | 585 | 682 | 95 | $103K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 552 | 685 | 97 | $64K |
Brand drugs: 15,642 claims; generic drugs: 19,969 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edna G Melendez Reyes $187 ($187 in general payments such as food, travel and fees) from 3 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $77.39.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.